Viewing Study NCT03067792


Ignite Creation Date: 2025-12-24 @ 3:48 PM
Ignite Modification Date: 2026-01-04 @ 7:13 AM
Study NCT ID: NCT03067792
Status: COMPLETED
Last Update Posted: 2017-03-01
First Post: 2017-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module